CILP1 as a biomarker for right ventricular dysfunction in patients with ischemic cardiomyopathy.

Pulm Circ · 2022 · PMC9052998 · PMID 35506075

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Patients with ICM showed a highly significant increase in median CILP1 ( p < 0.001; Figure S1a ) and NT‐proBNP ( p < 0.001; Figure S1b ) concentration as compared to the controls.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.